Cargando…
The opioid antagonist naltrexone decreases seizure‐like activity in genetic and chemically induced epilepsy models
OBJECTIVE: A significant number of epileptic patients fail to respond to available anticonvulsive medications. To find new anticonvulsive medications, we evaluated FDA‐approved drugs not known to be anticonvulsants. Using zebrafish larvae as an initial model system, we found that the opioid antagoni...
Autores principales: | Sturgeon, Morgan L., Langton, Rachel, Sharma, Shaunik, Cornell, Robert A., Glykys, Joseph, Bassuk, Alexander G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408599/ https://www.ncbi.nlm.nih.gov/pubmed/34664432 http://dx.doi.org/10.1002/epi4.12512 |
Ejemplares similares
-
Lacosamide decreases neonatal seizures without increasing apoptosis
por: Langton, Rachel L., et al.
Publicado: (2022) -
The relationship between reincarceration and treatment of opioid use disorder with extended-release naltrexone among persons with HIV
por: Parchinski, Kaley, et al.
Publicado: (2023) -
Fast Detection and Quantification of Interictal Spikes and Seizures in a Rodent Model of Epilepsy Using an Automated Algorithm
por: Kyle, Jackson J., et al.
Publicado: (2023) -
Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models
por: Patra, Pabitra Hriday, et al.
Publicado: (2018) -
Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study
por: O'Kelly, Brendan, et al.
Publicado: (2022)